Rycoben SC for Sheep
Frimley Business Park
A creamy pink coloured aqueous suspension containing 2.5% w/v ricobendazole (albendazole oxide) for the treatment of sheep. Contains 1.8% w/v
hydrated cobalt sulphate (equivalent to 3.77 mg of elemental cobalt/ml) and 0.19% w/v hydrated sodium selenate (equivalent to 0.41 mg of elemental
selenium/ml) as excipients.
Broad spectrum fluke and worm control for the major internal parasites of sheep including: Adult and immature gastro-intestinal roundworms: Bunostomum, Chabertia, Cooperia, Haemonchus, Nematodirus, Oesophagostomum, Ostertagia, Strongyloides
. Lungworms: Dictyocaulus filaria.
spp. Adult liver fluke: Fasciola hepatica
. Rycoben is ovicidal and is effective against mature and immature roundworms and lungworms. It is also effective against removing heads and segments of tapeworms. It controls adult liver fluke and treats chronic fasciolosis.
Dosage and administration
Rycoben should be administered orally with standard drenching equipment to sheep at a dosage rate of 5 mg ricobendazole per kg (1 ml per 5 kg bodyweight).
Fluke and worm dose
For the control of adult liver fluke and the treatment of chronic fasciolosis, in addition to the treatment of roundworm, lungworm and tapeworm infection in sheep
by oral administration at a dose rate of 7.5 mg ricobendazole per kg bodyweight (1½ ml per 5 kg bodyweight).
Ewes and gimmers
Dose ewes 2–6 weeks before lambing and again soon after lambing to reduce the periparturient rise of roundworm eggs and control chronic fluke disease. On
heavily stocked pastures, monthly treatments may be necessary until autumn. Otherwise treat prior to tupping and at housing.
Care should be taken not to exceed the recommended worm dose especially during the first month of pregnancy. Ewes should not be treated at the fluke and
worm dose during tupping and until one month after the tups are removed.
Ensure careful handling if used near lambing time.
Lambs and wetherhoggs
Dosing of lambs for Nematodirus infection should be based on the likely severity of the challenge. Otherwise treat in late May and repeat at 3 week intervals
until August. Dose at weaning and move to clean pasture. If clean pasture is unavailable, dose monthly until sold or until early winter.
Dose all sheep in August/September and repeat at 4–6 week intervals depending on the severity of the challenge. Treat all bought-in sheep before allowing to
mix with flock.
Contra-indications, warnings, etc
Rycoben has a wide safety margin when used at the recommended dose rates.
Rycoben is suitable for the treatment of sheep of all ages, and during pregnancy.
Rycoben is palatable and non-staining.
Assess bodyweight as accurately as possible.
Protection of consumers
Animals must not be slaughtered for human consumption during treatment.
Sheep may be slaughtered for human consumption only after 3 days from the last treatment.
Do not use in sheep producing milk for human consumption.
Wash hands after use. As with all animal health products, direct contact should be kept to a minimum.
For oral administration only.
For animal treatment only.
Store below 25°C. Protect from freezing. Store in original container, tightly closed in a safe place. Shake well before use. When finished, wash out
container throroughly and dispose of safely.
Keep out of reach of children.
0.8, 2.2 & 5 litre .
Marketing authorisation number
Journal of the American College of Cardiology© 2010 by the American College of Cardiology FoundationThe ARBITER 6-HALTS Trial(Arterial Biology for the Investigation of theTreatment Effects of Reducing Cholesterol 6 –HDL and LDL Treatment Strategies in Atherosclerosis)Final Results and the Impact ofMedication Adherence, Dose, and Treatment DurationTodd C. Villines, MD,* Eric J. Stanek, PHARM
CURRICULO VITAE Lair Geraldo Theodoro Ribeiro, M. D., F.A.C.C. EDUCATION Educational Foundation Machado Sobrinho, Medical School of the Federal University INTERNSHIP AND POSTGRADUATE TRAINING Residency in Cardiology, Pontificia Universidade Catolica of Rio de Janeiro (RJ), Brazil Research Fellow in Medicine, Peter Bent Brigham Hospital and Harvard Medical School, Boston (MA